TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
So if you're ready to stop guessing and start knowing what your body needs, head to the link in the show notes and join us
When combined with nutrients from Swolverine INTRA, it further supports hydration and cellular energy restoration
Analgesic and others modulatory roles of melatonin The molecular pathways underlying the analgesic action of melatonin have not been completely addressed, and a plethora of mechanisms have been proposed, such as endorphin release from the pituitary gland 83 , modulation of the central GABAergic system 84 , and additional interaction with multiple receptor types
